Stay updated on GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.

Latest updates to the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page
- CheckyesterdayChange DetectedThe study history now shows Revision: v3.5.5 added and Revision: v3.5.4 removed, updating the page's version trail.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe history now includes Revision: v3.5.4, replacing Revision: v3.5.3; this indicates a small software update for ClinicalTrials.gov without altering study details.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page’s displayed software/interface revision updates from version v3.5.2 to v3.5.3, without changing the underlying study record content.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision v3.5.0 was added to the Record History and revision v3.4.3 was removed.SummaryDifference0.1%

- Check86 days agoChange Detected- Added revision v3.4.3 to the Record History and removed v3.4.2, updating the page to reflect the latest revision.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 & Pembrolizumab in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.